IOL Chemical and Pharmaceuticals, a small cap company has seen 90 percent growth in revenue to Rs 142 crore year-on-year and has also got USFDA‘s approval to set a Ibuprofen manufacturing facility in Punjab.
first published: May 3, 2016 10:05 am
A collection of the most-viewed Moneycontrol videos.
The Lawyer Renting in one of Mumbai’s most green societies | The Tenant
Live: Nifty extends gain for the third day, up nearly 2% this week | Closing Bell | 4K
From renewables to AI and SMEs: Madhusudan Kela on where he senses opportunity now
Will The Pre-Diwali Nifty Rally Rage On Amid Weak Global Cues? RIL Q2 in Focus | Opening Bell Live
